Platelet function in pre-eclampsia
Platelet function in pre-eclampsia
Pronounced hemostatic changes occur during pregnancy, and the balance shifts markedly in favor of hypercoagulability. Although primarily a result of a marked rise in the levels of several procoagulants and a fall in some natural anticoagulants, platelet activation also contributes to this prothrombotic tendency. Several studies have confirmed the accentuation of platelet activation in pre-eclampsia (P-EC), which remains an important obstetric complication affecting ~2 to 4% of pregnancies. Although there is still a long way to go, significant inroads have been made in the understanding of this enigmatic condition. Whereas the pathogenesis of P-EC is protean and involves a complex interplay of placental and maternal tissues, platelet activation is likely to contribute to several clinical features. Several techniques have been used to assess platelet activation in P-EC. Detection of aberrations of platelet function and activation appear to have predictive value for its diagnosis. The findings also lend support to the use of antiplatelet agents as prophylaxis in those women with a high risk of developing the condition.
pre-eclampsia, platelet activation
131-136
Kazmi, Rashid
8b8d1641-1cc8-48e3-aa41-c134650cec3b
Cooper, Alan
9971af32-4b24-4794-b5b1-e4c78965e191
Lwaleed, Bashir A.
e7c59131-82ad-4a14-a227-7370e91e3f21
March 2011
Kazmi, Rashid
8b8d1641-1cc8-48e3-aa41-c134650cec3b
Cooper, Alan
9971af32-4b24-4794-b5b1-e4c78965e191
Lwaleed, Bashir A.
e7c59131-82ad-4a14-a227-7370e91e3f21
Abstract
Pronounced hemostatic changes occur during pregnancy, and the balance shifts markedly in favor of hypercoagulability. Although primarily a result of a marked rise in the levels of several procoagulants and a fall in some natural anticoagulants, platelet activation also contributes to this prothrombotic tendency. Several studies have confirmed the accentuation of platelet activation in pre-eclampsia (P-EC), which remains an important obstetric complication affecting ~2 to 4% of pregnancies. Although there is still a long way to go, significant inroads have been made in the understanding of this enigmatic condition. Whereas the pathogenesis of P-EC is protean and involves a complex interplay of placental and maternal tissues, platelet activation is likely to contribute to several clinical features. Several techniques have been used to assess platelet activation in P-EC. Detection of aberrations of platelet function and activation appear to have predictive value for its diagnosis. The findings also lend support to the use of antiplatelet agents as prophylaxis in those women with a high risk of developing the condition.
This record has no associated files available for download.
More information
e-pub ahead of print date: 2 March 2011
Published date: March 2011
Keywords:
pre-eclampsia, platelet activation
Organisations:
Faculty of Health Sciences
Identifiers
Local EPrints ID: 347870
URI: http://eprints.soton.ac.uk/id/eprint/347870
ISSN: 2567-689X
PURE UUID: 0530ff22-77ad-4ead-806d-035244bb3407
Catalogue record
Date deposited: 31 Jan 2013 15:19
Last modified: 06 Aug 2024 01:39
Export record
Altmetrics
Contributors
Author:
Rashid Kazmi
Author:
Alan Cooper
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics